Disclosures for "Disease Modifying Therapy Utilization in Pediatric Multiple Sclerosis: A Multi-center Retrospective Study"
-
Ms. Miller has nothing to disclose.
-
Ms. Held has nothing to disclose.
-
Mr. DeCesare has nothing to disclose.
-
Dr. Bassal has nothing to disclose.
-
Dr. Vaidyanathan has nothing to disclose.
-
Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.